These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9406689)

  • 1. Radioimmunoscintigraphy with a novel monoclonal antiprostate antibody (E4): an experimental study in nude mice.
    Rydh A; Riklund Ahlström K; Widmark A; Johansson L; Nilsson S; Bergh A; Damber JE; Stigbrand T; Hietala SO
    Cancer; 1997 Dec; 80(12 Suppl):2398-403. PubMed ID: 9406689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental radioimmunotargeting combining nonlabeled, iodine-125-labeled, and anti-idiotypic anticytokeratin monoclonal antibodies: a dosimetric evaluation.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2689-98. PubMed ID: 9406726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation.
    Rydh A; Riklund Ahlström K; Widmark A; Johansson L; Nilsson S; Bergh A; Damber JE; Stigbrand T; Hietala SO
    Urol Res; 2001 Jun; 29(3):216-20. PubMed ID: 11482450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of fractionated experimental radioimmunotargeting with idiotypic and anti-idiotypic anticytokeratin antibodies.
    Rossi Norrlund R; Ullén A; Sandström P; Holback D; Johansson L; Stigbrand T; Hietala SO; Riklund Ahlström K
    Cancer; 1997 Dec; 80(12 Suppl):2681-8. PubMed ID: 9406725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies for immunoscintigraphy of adenocarcinoma of the prostate with 125I-labeled monoclonal antibody to gamma-seminoprotein].
    Fujino A; Suyama K; Shidara T; Ao T; Ishibashi A; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1994 Feb; 85(2):271-80. PubMed ID: 8121109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and immunoreactivity of the monoclonal anticytokeratin antibody TS1 after different degrees of iodination.
    Johansson A; Sandström P; Ullén A; Erlandsson A; Sundström B; Ahlström KR; Johansson L; Hietala SO; Stigbrand T
    Acta Oncol; 1999; 38(3):329-34. PubMed ID: 10380824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of DU-145 tumours in nude mice--a pilot study with E4, a novel monoclonal antibody against prostate cancer.
    Rydh A; Riklund-Ahlström K; Widmark A; Bergh A; Johansson L; Tavelin B; Nilsson S; Stigbrand T; Damber JE; Hietala SO
    Acta Oncol; 1999; 38(8):1075-9. PubMed ID: 10665766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetry of fractionated administration of 125I-labeled antibody at experimental radioimmunotargeting.
    Ullén A; Sandström P; Rossi Norrlund R; Rathsman S; Johansson L; Riklund Ahlström K; Hietala SO; Stigbrand T
    Cancer; 1997 Dec; 80(12 Suppl):2510-8. PubMed ID: 9406704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anticytokeratin monoclonal anti-idiotypic antibodies to improve tumor:nontumor ratio in experimental radioimmunolocalization.
    Ullén A; Sandström P; Ahlström KR; Sundström B; Nilsson B; Arlestig L; Stigbrand T
    Cancer Res; 1995 Dec; 55(23 Suppl):5868s-5873s. PubMed ID: 7493362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of 111In- and 125I-labeled monoclonal antibody 17-1A in mice bearing xenografts of human pancreatic carcinoma HuP-T4.
    Maeda M; Shoji M; Kawagoshi T; Futatsuya R; Honda T; Brady LW
    Cancer; 1994 Feb; 73(3 Suppl):800-7. PubMed ID: 8306263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting free prostate-specific antigen for in vivo imaging of prostate cancer using a monoclonal antibody specific for unique epitopes accessible on free prostate-specific antigen alone.
    Evans-Axelsson S; Ulmert D; Örbom A; Peterson P; Nilsson O; Wennerberg J; Strand J; Wingårdh K; Olsson T; Hagman Z; Tolmachev V; Bjartell A; Lilja H; Strand SE
    Cancer Biother Radiopharm; 2012 May; 27(4):243-51. PubMed ID: 22489659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunodetection of prostatic cancer with 125I-labelled antibody against prostatic specific antigen.
    Larson A; Arnberg H; Maripuu E; Nilsson S
    Scand J Urol Nephrol Suppl; 1988; 110():149-53. PubMed ID: 2460917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy of xenotransplanted hepatoblastoma with iodine 131-labeled anti-alpha-fetoprotein monoclonal antibody.
    Fuchs J; Gratz KF; Habild G; Gielow P; von Schweinitz D; Baum RP
    J Pediatr Surg; 1999 Sep; 34(9):1378-84. PubMed ID: 10507433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): studies in nude mice.
    Vallabhajosula S; Smith-Jones PM; Navarro V; Goldsmith SJ; Bander NH
    Prostate; 2004 Feb; 58(2):145-55. PubMed ID: 14716739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotargeting with monoclonal cytokeratin 8 antibodies of human urothelial cancer transplanted to nude mice.
    Letocha H; Nilsson S; Silén A; Ekblom J; Arnberg H; Wiklund B; Westlin JE
    Acta Oncol; 1993; 32(7-8):793-800. PubMed ID: 7508236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of nonlabeled, 125I-labeled, and anti-idiotypic antiplacental alkaline phosphatase monoclonal antibodies at experimental radioimmunotargeting.
    Rossi Norrlund R; Holback D; Johansson L; Hietala SO; Ahlström KR
    Acta Radiol; 1997 Nov; 38(6):1087-93. PubMed ID: 9394676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.
    Zhang M; Yao Z; Saga T; Sakahara H; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1998 Jan; 39(1):30-3. PubMed ID: 9443734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor.
    Smith-Jones PM; Vallabhajosula S; Navarro V; Bastidas D; Goldsmith SJ; Bander NH
    J Nucl Med; 2003 Apr; 44(4):610-7. PubMed ID: 12679407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.